These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20701617)

  • 1. Sublingual immunotherapy affects transforming growth factor-beta and nasal eosinophils.
    Ciprandi G; Tosca MA
    Clin Exp Allergy; 2010 Sep; 40(9):1431-2; author reply 1432. PubMed ID: 20701617
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.
    Ford SA; Baroody FM; Naclerio RM
    Rhinol Suppl; 1992; 14():52-6. PubMed ID: 1389403
    [No Abstract]   [Full Text] [Related]  

  • 3. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis.
    Ciprandi G; De Amici M; Tosca M; Marseglia G
    Int Arch Allergy Immunol; 2010; 152(1):66-70. PubMed ID: 19940507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy.
    Corrigan C
    J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy.
    Ventura MT; Carretta A; Tummolo RA; Buquicchio R; Arsieni A; Murgia N
    Int J Immunopathol Pharmacol; 2009; 22(2):403-13. PubMed ID: 19505393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topical nasal hypersensitization in the treatment of perennial rhinitis, with water extracts of dust and Dermatophagoides. I. Preliminary study].
    Campos A; Basomba A; Peláez A; García Villalmanzo I
    Allergol Immunopathol (Madr); 1979; 7(3):217-22. PubMed ID: 474329
    [No Abstract]   [Full Text] [Related]  

  • 9. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR; Riis B
    Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 13. Sublingual immunotherapy.
    Frew AJ
    N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
    [No Abstract]   [Full Text] [Related]  

  • 14. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen.
    Rondón C; Blanca-López N; Aranda A; Herrera R; Rodriguez-Bada JL; Canto G; Mayorga C; Torres MJ; Campo P; Blanca M
    J Allergy Clin Immunol; 2011 Apr; 127(4):1069-71. PubMed ID: 21277626
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylaxis to multiple pollen allergen sublingual immunotherapy.
    Eifan AO; Keles S; Bahceciler NN; Barlan IB
    Allergy; 2007 May; 62(5):567-8. PubMed ID: 17313400
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study.
    Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2005 Jun; 115(6):1184-8. PubMed ID: 15940132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pollen immunotherapy in seasonal allergic rhinitis.
    Can D; Tanaç R; Demir E; Gülen F; Veral A
    Pediatr Int; 2007 Feb; 49(1):64-9. PubMed ID: 17250508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta and IL-17 serum levels and specific immunotherapy.
    Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA
    Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rush immunotherapy with sublingual administration of grass allergen extract.
    Feliziani V; Marfisi RM; Parmiani S
    Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.